James M Littlewood

Summary

Country: UK

Publications

  1. ncbi A 2-year post-authorization safety study of high-strength pancreatic enzyme replacement therapy (pancreatin 40,000) in cystic fibrosis
    James M Littlewood
    UK Cystic Fibrosis Trust, 11 London Road, Bromley, Kent BR1 1BY, UK
    Expert Opin Drug Saf 10:197-203. 2011
  2. ncbi Diagnosis and treatment of intestinal malabsorption in cystic fibrosis
    James M Littlewood
    Regional Paediatric Cystic Fibrosis Unit, St James s University Hospital, Leeds, UK
    Pediatr Pulmonol 41:35-49. 2006
  3. ncbi Evaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis patients
    Tim W R Lee
    Leeds Regional Paediatric Cystic Fibrosis Centre, St James s Hospital, Leeds, UK
    J Cyst Fibros 2:29-34. 2003
  4. ncbi Reduction in prevalence of chronic Pseudomonas aeruginosa infection at a regional pediatric cystic fibrosis center
    Tim W R Lee
    Leeds Regional Paediatric Cystic Fibrosis Unit, St James s University Hospital, Leeds, United Kingdom
    Pediatr Pulmonol 37:104-10. 2004
  5. ncbi Newborn screening programmes for cystic fibrosis
    Kevin W Southern
    Institute of Child Health, University of Liverpool, Royal Liverpool Children s Hospital, Alder Hey, Liverpool L12 2AP, UK
    Paediatr Respir Rev 4:299-305. 2003

Detail Information

Publications5

  1. ncbi A 2-year post-authorization safety study of high-strength pancreatic enzyme replacement therapy (pancreatin 40,000) in cystic fibrosis
    James M Littlewood
    UK Cystic Fibrosis Trust, 11 London Road, Bromley, Kent BR1 1BY, UK
    Expert Opin Drug Saf 10:197-203. 2011
    ....
  2. ncbi Diagnosis and treatment of intestinal malabsorption in cystic fibrosis
    James M Littlewood
    Regional Paediatric Cystic Fibrosis Unit, St James s University Hospital, Leeds, UK
    Pediatr Pulmonol 41:35-49. 2006
    ....
  3. ncbi Evaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis patients
    Tim W R Lee
    Leeds Regional Paediatric Cystic Fibrosis Centre, St James s Hospital, Leeds, UK
    J Cyst Fibros 2:29-34. 2003
    ....
  4. ncbi Reduction in prevalence of chronic Pseudomonas aeruginosa infection at a regional pediatric cystic fibrosis center
    Tim W R Lee
    Leeds Regional Paediatric Cystic Fibrosis Unit, St James s University Hospital, Leeds, United Kingdom
    Pediatr Pulmonol 37:104-10. 2004
    ..aeruginosa did not alter significantly. In conclusion, antipseudomonal management strategies were associated with both reduced prevalence, and an increase in the mean age of onset of chronic P. aeruginosa infection...
  5. ncbi Newborn screening programmes for cystic fibrosis
    Kevin W Southern
    Institute of Child Health, University of Liverpool, Royal Liverpool Children s Hospital, Alder Hey, Liverpool L12 2AP, UK
    Paediatr Respir Rev 4:299-305. 2003
    ..Whichever algorithm is selected, the implementation of a successful programme relies on clear pathways and good information for parents...